Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Type 2 DiabetesPsychiatryIssue 681

Association between Smoking and Depression in Type 2 Patients

Smoking and depression are strongly associated in patients with type 2 diabetes....

Advertisement

The study population for the trial included a total of 1,868 adults with type 2 diabetes. Smoking was assessed in the study with five different categories which included: never, former, light (≤10 cigarettes a day) and moderate/heavy (11+ cigarettes a day). Depression was assessed and categorized in the study using a Patient Health Questionnaire. Depression was classified in a binary fashion in this study and patients were recorded as either having no major depression or major depression syndrome. To make sense of the relationship between individual's smoking activity and the presence of depression a statistical analysis using a logistic regression was used, while controlling for other demographic and health-related variables.

After the procedures of the study were carried out, the results showed that major depression was indeed associated with an augmented likelihood of being a smoker in any of the categories (light (≤10 cigarettes a day) and moderate/heavy (11+ cigarettes a day)). Depression; however, was also increased in the patients having 2 or more diabetes complications, moderate-severe disability or having 2 or more other chronic illnesses. In the fully adjusted study model, having major depression was associated with an increased likelihood of being a moderate or heavy smoker (odds ratio = 2.62, 95% confidence interval = 1.43–4.81). The statistical analysis from the study also showed that the association between a light smoker and major depression was not significant when adjusting for confounding variables.

Researchers concluded that smoking and depression are strongly associated in patients with type 2 diabetes. The association between smoking and the presence of major depression syndrome was strongest for diabetic patients classified as either moderate or heavy smokers. These findings potentially mean that depression may be a significant consideration when targeting clients with diabetes who continue to smoke and optimal mental health may not be obtainable until smoking cessation is achieved.

Matthew Clyde, Geneviève Smith, Norbert Gariépy, et al. Canadian Journal of Diabetes. Association between Smoking and Depression in a Canadian Community-Based Sample with Type 2 Diabetes. Vol. 37, Issue 3, June 4, 2013 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 13 June, 2013 and appeared in  Type 2 DiabetesPsychiatryIssue 681

Past five issues: Issue 760 | Diabetes Clinical Mastery Series Issue 219 | SGLT-2 Inhibitors Special Edition December 2014 | Issue 759 | Diabetes Clinical Mastery Series Issue 218 |

2014 Most Popular Articles:

New Guidelines for Doctors to Treat Diabetes
Posted December 12, 2014
Handbook of Diabetes, 4th Ed., Excerpt #20: Foot Problems in Diabetes
Posted November 29, 2014
Why Are Up to 20% Type 2's Nonresponsive to Exercise?
Posted December 05, 2014
Is Type 2 Diabetes an Inflammatory Disease?
Posted November 21, 2014
Carbs Associated with Higher Diabetes and Heart Disease Risk Factor
Posted December 05, 2014
Handbook of Diabetes, 4th Ed., Excerpt #19: Macrovascular Disease in Diabetes
Posted November 23, 2014
Any Pain Medication Said Effective When Treating Diabetic Nerve Pain
Posted November 21, 2014
Knowledge of Onset, Peak, and Duration of Action of Meds Prevents a Trip to the ER
Posted November 24, 2014
Link between Free Fatty Acids and Acute MI, Type 2 Diabetes
Posted November 21, 2014
New Approach Targets Type 2's Poorly Controlled With Metformin
Posted November 14, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
For your prediabetes patients who can't lower their blood glucose with lifestyle changes, do you prescribe GLP-1s or SGLT-2s?
CME/CE of the Week
Jeffrey M. Robbins, DPM

Category: General Diabetes
Credits: .5
Search Articles On Diabetes In Control